p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
The molecular archaeology of the mutation spectra of tumor suppressor genes generates hypotheses concerning the etiology and molecular pathogenesis of human cancer. The spectrum of somatic mutations in the p53 gene implicates environmental carcinogens and both endogenous agents and processes in the etiology of human cancer.
Hussain
S P
SP
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255, USA.
Hollstein
M H
MH
Harris
C C
CC
D016604:Aflatoxin B1 / Q000633:toxicity; D002273:Carcinogens / Q000494:pharmacology; D004252:DNA Mutational Analysis; D016158:Genes, p53 / Q000235:genetics* / Q000502:physiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000235:genetics; D009153:Mutagens / Q000494:pharmacology; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics*; D009857:Oncogenes / Q000235:genetics; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000209:etiology / Q000235:genetics; D013472:Sunlight / Q000009:adverse effects
D002273:Carcinogens; D009153:Mutagens; D016604:Aflatoxin B1